Australian and New Zealand Bone and Mineral Society

Last updated

Australian and New Zealand Bone and Mineral Society
AbbreviationANZBMS
PredecessorSeries of bone research symposia
Formation1988 (1988)
FounderProfessor Thomas John (Jack) Martin
PurposePrincipal professional body for scientists and clinicians involved in bone and mineral metabolism research in Australia and New Zealand
Region
Australia and New Zealand
ServicesBone research
Membership
Over 500
Key people
Sol Posen, Roger Melick, Christopher and Margie Nordin
AffiliationsInternational Congress on Calcium Regulating Hormones, International Osteoporosis Foundation, Japanese Society for Bone and Mineral Research
DisbursementsSeveral grants and awards

The Australian and New Zealand Bone and Mineral Society (ANZBMS) is a not-for-profit collegiate organisation and principal professional body for scientists and clinicians involved in bone and mineral metabolism research in Australia and New Zealand.

Contents

Since its inception in 1988, the ANZBMS has become one of the premier bone research societies in Australia, with its members recognised for their outstanding contributions made to clinical and biomedical musculoskeletal research. The ANZBMS continues to act as a policy advisor to governments [1] and the community [2] [3] throughout Australasia on issues such as clinical bone disease and funding for musculoskeletal research.

Aims and purpose of the Society

The major goal of the ANZBMS is the nurturing, development and dissemination of new knowledge regarding bone and mineral metabolism, with particular emphasis on issues of clinical relevance. The ANZBMS aims to promote excellence in bone and mineral research, to foster the integration of clinical and basic science, and to facilitate the translation of our science to health care. The society prides itself of its continued and successful activities to advance the education of clinicians, allied health professionals and the public in the nature of and management of diseases impacting upon the skeleton.

History

The ANZBMS developed from a series of bone research symposia held in the late 1970s and early 1980s throughout Australia and New Zealand, which eventually led to the founding of the society at the Auckland Bone Symposium in 1988, with Professor Thomas John (Jack) Martin [4] as its inaugural president. The first annual meeting was held in Perth in 1990. [5] Since then, the society has continued to hold successful scientific meetings on an annual basis, with a focus on biomedical and clinical research in musculoskeletal biology and disease.

Over the last decade, the ANZBMS membership has grown continuously and is now over 500. The ANZBMS maintains regular contact with its members through its website and e-newsletters. [6] A strategic plan, drafted by ANZBMS Council in 2006, aimed to enhance membership involvement and implement initiatives to encourage young investigators to pursue careers in bone and mineral research. The ANZBMS has developed, and strongly supports, advocacy initiatives to facilitate increased funding for bone research from governmental and non-governmental sources in both Australia and New Zealand. Members of the society actively address clinical and basic science issues [7] [8] [9] and take leadership roles in identifying, defining and then developing strategic plans to address key problems in basic and clinical musculoskeletal science. [10] [11]

National and international collaboration

The ANZBMS liaises extensively with other international societies with shared interests. The first joint meeting with the International Congress on Calcium Regulating Hormones (later to become the International Bone and Mineral Society or IBMS) was held in Melbourne in 1995. This relationship was further strengthened with the 2000 International Bone and Hormone Meeting held on Hamilton Island and the 2007 joint meeting in Sydney. In 1999, the ANZBMS joined the Committee of National Societies of the International Osteoporosis Foundation (IOF).

In 2011, the ANZBMS hosted the 2nd IOF Asia-Pacific Osteoporosis and Bone Meeting, a high calibre scientific event held in conjunction with the Japanese Society for Bone and Mineral Research. In 2012, the ANZBMS became the third society to establish a firm partnership with the International Bone and Mineral Society, facilitating scientific collaboration and open access to the BoneKey knowledge environment. Other member societies of IBMS are the Spanish Research Society for Bone and Mineral Metabolism (SEIOMM) and the Japanese Society for Bone and Mineral Research (JSBMR). [12]

The ANZBMS maintains close links to Osteoporosis Australia, a not-for-profit organisation that is the main consumer body in the bone area in Australia.

ANZBMS Council

A democratically elected council governs the affairs of ANZBMS. The council consists of the president, immediate past president, president elect, treasurer, secretary and further members from New Zealand and each Australian state. View current and past council members.

Education

The ANZBMS organises and runs high quality scientific meetings [13] to fulfill the educational and collaborative needs of researchers and clinicians working in bone diseases across Australia, New Zealand and internationally.

In addition to its Annual Scientific Meeting, the Society runs a number of educational and training courses. The first ANZBMS Bone Densitometry Course was held in Sydney in 2001, providing a high quality accreditation programme that quickly became an integral annual part of the Society's educational programme. The ANZBMS Advanced Clinical Postgraduate Meetings in Bone Disease, held biannually across Australia and New Zealand, focuses on clinical aspects of musculoskeletal biology and disease and targets younger members of the scientific and clinical community.

Awards

In 2002, an AU$15,000 travel grant was created by the ANZBMS in memory of Christine Martin and to honour the scientific contributions of Professor Jack Martin. This grant facilitates the travel of ANZBMS members to undertake bone and mineral research in any aspect of basic or clinical science.

The ANZBMS also offers several other grants and awards [14] that recognise the high standard of bone and mineral research and promote education. These include the Sol Posen Research Award, the Roger Melick Young Investigator Award, the Christopher and Margie Nordin Young Investigator Poster Award, the Kaye Ibbertson Award for Bone and Mineral Medicine, the ANZBMS Career Achievement Award and, in conjunction with Osteoporosis Australia, the Philip Sambrook Award. [15] These and a number of other (travel) awards are available to financial members of ANZBMS.

See also

Related Research Articles

<span class="mw-page-title-main">Osteoporosis</span> Skeletal disorder

Osteoporosis is a systemic skeletal disorder characterized by low bone mass, micro-architectural deterioration of bone tissue leading to bone sterility, and consequent increase in fracture risk. It is the most common reason for a broken bone among the elderly. Bones that commonly break include the vertebrae in the spine, the bones of the forearm, the wrist, and the hip. Until a broken bone occurs there are typically no symptoms. Bones may weaken to such a degree that a break may occur with minor stress or spontaneously. After the broken bone heals, the person may have chronic pain and a decreased ability to carry out normal activities.

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is one of the institutes and centers that make up the National Institutes of Health, an agency of the United States Department of Health and Human Services (HHS).

<span class="mw-page-title-main">Osteopenia</span> Medical condition

Osteopenia, known as "low bone mass" or "low bone density", is a condition in which bone mineral density is low. Because their bones are weaker, people with osteopenia may have a higher risk of fractures, and some people may go on to develop osteoporosis. In 2010, 43 million older adults in the US had osteopenia. Unlike osteoporosis, osteopenia does not usually cause symptoms, and losing bone density in itself does not cause pain.

Renal osteodystrophy/adynamic bone disease is currently defined as an alteration of bone morphology in patients with chronic kidney disease (CKD). It is one measure of the skeletal component of the systemic disorder of chronic kidney disease-mineral and bone disorder (CKD-MBD). The term "renal osteodystrophy" was coined in 1943, 60 years after an association was identified between bone disease and kidney failure.

<span class="mw-page-title-main">Orthopaedic Research Society</span>

The Orthopaedic Research Society (ORS) is a professional, scientific, and medical organization focused on orthopaedic research. The stated mission of the ORS is to advance orthopaedic research through education, collaboration, communication, and advocacy. The ORS aims to raise resources for orthopaedic research and increase the awareness of the impact of such research on patients and the public. Annual meetings are held across the US to discuess current research, with a number of awards available to further career trajectories of members.

The International Bone and Mineral Society (IBMS) is a learned society in the field of bone and mineral metabolism, including osteoporosis and other diseases of bone.

Senile osteoporosis has been recently recognized as a geriatric syndrome with a particular pathophysiology. There are different classification of osteoporosis: primary, in which bone loss is a result of aging and secondary, in which bone loss occurs from various clinical and lifestyle factors. Primary, or involuntary osteoporosis, can further be classified into Type I or Type II. Type I refers to postmenopausal osteoporosis and is caused by the deficiency of estrogen. While senile osteoporosis is categorized as an involuntary, Type II, and primary osteoporosis, which affects both men and women over the age of 70 years. It is accompanied by vitamin D deficiency, body's failure to absorb calcium, and increased parathyroid hormone.

The American Society for Bone and Mineral Research (ASBMR) is a professional, scientific and medical society established in 1977 to promote excellence in bone and mineral research and to facilitate the translation of that research into clinical practice. The ASBMR has a membership of nearly 4,000 physicians, basic research scientists, and clinical investigators from around the world.

<span class="mw-page-title-main">Royal Osteoporosis Society</span> Charity in the United Kingdom

The Royal Osteoporosis Society (ROS), formerly the National Osteoporosis Society, established in 1986, is the only UK-wide charity dedicated to improving the prevention, diagnosis and treatment of osteoporosis. It is based in Camerton, Somerset, England.

Richard Eastell MD, FRCP, FRCPath, FMedSci is a British medical doctor and Professor of Bone Metabolism at the University of Sheffield. He was born in Shipley and attended the Salt Grammar School, later graduating from the University of Edinburgh in 1977 with an MB ChB and in 1984 with an MD and achieved prominence as an expert in osteoporosis.

<span class="mw-page-title-main">International Osteoporosis Foundation</span> Organization

The International Osteoporosis Foundation (IOF), headquartered in Nyon, Switzerland, is a non-governmental organization (NGO) founded in 1998. It was formed from the merger of the European Foundation for Osteoporosis, founded in 1987, and the International Federation of Societies on Skeletal Diseases. The foundation functions as a global alliance of individuals and organizations concerned with the prevention, diagnosis and treatment of osteoporosis and musculoskeletal bone disease. The goal of the Foundation is to increase the early detection of osteoporosis and related musculoskeletal diseases, as well as to improve the treatment of these conditions through international collaboration among national healthcare systems and governments. The Foundation is the largest global NGO dedicated to osteoporosis and musculoskeletal diseases.

Professor Caryl Nowson holds the Chair in Nutrition and Ageing in the School of Exercise and Nutrition Sciences at Deakin University, Melbourne, Australia. She is also the team leader of the "Healthy Growing, Healthy Ageing" group within the Centre for Physical Activity and Nutrition Research (C-PAN) at Deakin.

Shashank R. Joshi is an Indian endocrinologist, diabetologist and medical researcher, considered by many as one of the prominent practitioners of the trade in India. He was honoured by the Government of India, in 2014, by bestowing on him the Padma Shri, the fourth highest civilian award, for his services to the field of medicine. He is a part of the COVID-19 Task Force for the state of Maharashtra, India.

Ambrish Mithal is an Indian endocrinologist and the Chairman and Head of Endocrinology and Diabetes at Max Healthcare- Pan-Max, Saket, New Delhi, where he started working in December 2019. He secured the master's degree (DM) from the All India Institute of Medical Sciences, New Delhi, and subsequently worked at Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow and, later, at Apollo Hospitals, New Delhi before joining Medanta the Medicity as Chairman, Division of Endocrinology and Diabetes where he worked from 2009 to 2019. Mithal was honoured by the Government of India in 2015 with Padma Bhushan, the third highest Indian civilian award, for his outstanding contribution to the field of medicine. In September 2020 Dr Mithal became the first Indian to be chosen for the Laureate Award for International Excellence in Endocrinology (2021) by the Endocrine Society (US).

Jane A. Cauley is a Distinguished Professor in the Department of Epidemiology and an Associate Dean for Research at the University of Pittsburgh.

<span class="mw-page-title-main">Bone marrow adipose tissue</span>

Bone marrow adipose tissue (BMAT), sometimes referred to as marrow adipose tissue (MAT), is a type of fat deposit in bone marrow. It increases in states of low bone density -osteoporosis, anorexia nervosa/ caloric restriction, skeletal unweighting such as that which occurs in space travel, and anti-diabetes therapies. BMAT decreases in anaemia, leukaemia, and hypertensive heart failure; in response to hormones such as oestrogen, leptin, and growth hormone; with exercise-induced weight loss or bariatric surgery; in response to chronic cold exposure; and in response to pharmacological agents such as bisphosphonates, teriparatide, and metformin.

Jillian Cornish is a New Zealand biomedical researcher. She is currently a full professor at the University of Auckland.

<span class="mw-page-title-main">Radiofrequency Echographic Multi Spectrometry</span> Medical diagnostic

Radiofrequency Echographic Multi Spectrometry (REMS) is a non-ionizing technology for osteoporosis diagnosis and for fracture risk assessment. REMS processes the raw, unfiltered ultrasound signals acquired during an echographic scan of the axial sites, femur and spine. The analysis is performed in the frequency domain. Bone mineral density (BMD) is estimated by comparing the results against reference models.

Locomotive syndrome is a medical condition of decreased mobility due to disorders of the locomotor system. The locomotor system comprises bones, joints, muscles and nerves. It is a concept put forward by three professional medical societies in Japan: the Japanese Society for Musculoskeletal Medicine, the Japanese Orthopaedic Association, and the Japanese Clinical Orthopaedic Association. Locomotive syndrome is generally found in the ageing population as locomotor functions deteriorate with age. Symptoms of locomotive syndrome include limitations in joint mobility, pain, balance disorder, malalignment and gait abnormality. Locomotive syndrome is commonly caused by chronic locomotive organ diseases. Diagnosis and assessment of locomotive syndrome is done using several tests such as the stand-up and two-step tests. The risk of having locomotive syndrome can be decreased via adequate nutrition, attainment of an exercise habit and being active.

Lynda Bonewald is a professor of anatomy, cell biology, physiology, and orthopaedic surgery and the founding director of the Indiana Center for Musculoskeletal Health (ICMH) at the Indiana University School of Medicine. She studies bone and the musculoskeletal system. She has served as president of the American Society for Bone and Mineral Research and the Association of Biomolecular Resource Facilities (1999-2000).

References

  1. ↑ "Clinical Practice Guidelines Portal". Australian Government – National Health and Medical Research Council. Archived from the original on 16 June 2014. Retrieved 16 June 2014.
  2. ↑ "How to keep your bones strong". La Trobe University. Retrieved 16 June 2014.
  3. ↑ "Vitamin D". Australian Government Department of Health. Archived from the original on 25 February 2014. Retrieved 16 June 2014.
  4. ↑ "Martin, T. John". Trove. 2011. Retrieved 14 May 2014.
  5. ↑ "Australian and New Zealand Bone and Mineral Society 25 Year Anniversary Newsletter" (PDF). ANZBMS News. September 2013. Retrieved 9 May 2014.
  6. ↑ "ANZBMS News Items and Updates" . Retrieved 9 May 2014.
  7. ↑ "Statement about Numerous Errors in Tuesday night's story on Osteonecrosis of the Jaw (ONJ)" (PDF). ANZBMS. Archived from the original (PDF) on 26 January 2014. Retrieved 14 May 2014.
  8. ↑ Grimm, Nick (11 December 2007). "The 7:30 Report – Concern over osteoporosis drug". Australian Broadcasting Corporation. Retrieved 14 May 2014.
  9. ↑ "ABC 7:30 Report Response Letter – 8 Feb 2008" (PDF). Retrieved 24 May 2014.
  10. ↑ Wilson, Pamela (3 April 2012). "Vitamin D: how do you know if you're getting enough?". ABC Health and Wellbeing – The Pulse. Retrieved 14 May 2014.
  11. ↑ Throsby, Margaret (6 October 2011). "Professor Rebecca Mason talks about Vitamin D". ABC Classic FM. Archived from the original on 23 February 2014. Retrieved 16 June 2014.
  12. ↑ "2013 Annual Report" (PDF). Australia and New Zealand Bone and Mineral Society. 2013. Retrieved 9 May 2014.
  13. ↑ "ANZBMS Conferences". Archived from the original on 17 May 2014. Retrieved 9 May 2014.
  14. ↑ "ANZBMS Grants and Awards" . Retrieved 9 May 2014.
  15. ↑ Aubusson, Kate (19 April 2012). "Professor Sambrook passes away, award announced in his honour". Endocrinology Update. Archived from the original on 14 March 2014. Retrieved 14 May 2014.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.